Creyon Bio Competitors and Similar CompaniesClear all

Creyon Bio's competitors and similar companies include Amyris, Caribou Biosciences and Editas Medicine.

	Creyon Bio Creyon Bio is a reinventing drug development company that develops oligonucleotide-based medicines (OBMs).	Amyris Amyris is a biotechnology research company that develops sustainable ingredients for the clean health and beauty markets.	Caribou Biosciences Caribou Biosciences is a leading biotechnology company in genome engineering. We develop technology-based solutions for cellular.	Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Founding Date	Founding Date 2019	Founding Date 2003	Founding Date 2011	Founding Date 2013
Type	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics
Locations	Locations Carlsbad, US HQ Bengaluru, IN Durham, US	Locations Emeryville, US HQ Sao Paulo, BR	Locations Berkeley, US HQ	Locations Cambridge, US HQ Boulder, US Cambridge, US
Employees	Employees 62	Employees 1,033	Employees 1631% increase	Employees 20816% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 171.7 m	Valuation ($) 289.1 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $269.8m (FY, 2022)	Revenue (est.) $34.5m (FY, 2023)	Revenue (est.) $78.1m (FY, 2023)
Net income	Net income N/A	Net income ($543.4m) (FY, 2022)	Net income ($102.1m) (FY, 2023)	Net income ($153.2m) (FY, 2023)
Funding
Latest funding round	Latest funding round $ 40m (over 2 years ago)	Latest funding round $ 34m (over 5 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 40m	Total funding raised $ 551.9m	Total funding raised $ 159.5m	Total funding raised $ 210m